MCM
ISEE

Moore Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Moore Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-171,241
Closed -$4.17M – 618
2023
Q1 		$4.17M Sell
171,241
-38,759
-18% -$849K 0.09% 179
2022
Q4 		$4.5M Sell
210,000
-29,944
-12% -$639K 0.11% 171
2022
Q3 		$4.3M Buy
+239,944
New +$3.15M 0.1% 223
2022
Q1 		– Sell
-68,829
Closed -$1.15M – 890
2021
Q4 		$1.15M Sell
68,829
-316,977
-82% -$5.2M 0.02% 452
2021
Q3 		$6.26M Buy
+385,806
New +$4.2M 0.1% 214

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Moore Capital Management's ISEE Position: Q2 2023 in Review

Moore Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 171,241 shares — an estimated $4.17M sold.

Moore Capital Management first reported a position in ISEE in Q3 2021 and held it in 5 quarters. The position peaked at $6.26M in Q3 2021. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Moore Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Moore Capital Management sold 171,241 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $4.17M.
  • Moore Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Moore Capital Management's IVERIC bio, Inc. Common Stock position peaked at $6.26M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Moore Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.